HIMS Hims & Hers Health, Inc.
Q3 2025 10-Q
Filed: Nov 3, 2025Period ending Sep 30, 2025
Health Care
Services-Offices & Clinics of Doctors of MedicineSEC EDGAR Hims & Hers Health, Inc. (HIMS) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 3, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New risk: Constraints on compounded semaglutide supply post FDA shortage resolution May 2025 impacting access and pricing, triggered by evolving GLP-1 regulatory landscape
- • Most updated risk: Rapid revenue growth to $1.48B in 2024 with headcount up to 1,637 increases operational strain and requires improved management controls
Get deeper insights on Hims & Hers Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.